Table 2.
Outcomes of patients with severe COVID-19 pneumonia and in-hospital cardiac arrest in Wuhan.
| Group | N | ROSC |
30-day survival |
||||
|---|---|---|---|---|---|---|---|
| n (%) | p-Value | OR (95% CI) | n (%) | p-Value | OR (95% CI) | ||
| Age, years | 0.08 | 0.19 | |||||
| >60 | 105 | 11 (10.5) | 1.00 | 2 (1.9) | 1.00 | ||
| ≤60 | 31 | 7 (22.6) | 2.49 (0.87–7.11) | 2 (6.5) | 3.55 (0.48–26.32) | ||
| Sex | 0.12 | 0.15 | |||||
| Female | 46 | 9 (19.6) | 1.00 | 0 (0) | 1.00 | ||
| Male | 90 | 9 (10) | 0.46 (0.17–1.25) | 4 (4.4) | 4.28 (0.22–82.71) | ||
| Location | <0.01 | <0.01 | |||||
| General ward | 113 | 8 (7.1) | 1.00 | 1 (1) | 1.00 | ||
| ICU | 23 | 10 (43.5) | 10.10 (3.38–30.14) | 3 (13) | 16.80 (1.66–169.70) | ||
| Witnessed | 0.43 | 0.72 | |||||
| No | 4 | 0 (0) | 1.000 | 0 (0) | 1.00 | ||
| Yes | 132 | 18 (13.6) | 1.26 (0.06–24.91) | 4 (3) | 0.25 (0.01–5.57) | ||
| Aetiology | 0.48 | 0.36 | |||||
| Cardiac | 10 | 2 (20) | 1.000 | 1 (10) | 1.00 | ||
| Respiratory | 119 | 16 (13.4) | 0.62 (0.12–3.19) | 3 (2.5) | 0.23 (0.02–2.47) | ||
| Others | 7 | 0 (0) | 0.29 (0.01–7.45) | 0 (0) | 0.64 (0.02–22.06) | ||
| Initial rhythm | <0.01 | <0.01 | |||||
| VF/VT | 8 | 6 (75.0) | 1.000 | 3 (37.5) | 1.00 | ||
| PEA | 6 | 1 (16.7) | 0.07 (0.01–0.97) | 0 (0) | 0.14 (0.01–3.48) | ||
| Asystole | 122 | 11 (9) | 0.03 (0.01–0.18) | 1 (0.8) | 0.01 (0.00–0.16) | ||
ROSC, return of spontaneous circulation; OR, odds ratio; CI, confidence interval; ICU, intensive care unit; PEA, pulseless electrical activity; VF, ventricular fibrillation; VT, pulseless ventricular tachycardia.